March 2014, Vol. 104, No. 3 at the start of the trial gained weight on the low-fat diet' . [2] While the leanest women in the intervention group did indeed gain weight, this was also true for the leanest women in the control group. [4] In fact, women in the intervention group had significantly lower weight than those in the control group among women with a body mass index <25 kg/m 2 at baseline. [4] May this result simply reflect that the leanest women were more susceptible to weight gain, regardless of assigned diet? It is important to remember that this trial was conducted at the same time that prevalence of obesity in the US increased, [5] and increases in weight for a proportion of participants would be expected due to myriad changes in the environment.
A second issue with Prof. Noakes' critique is the statement that, 'those with the least insulin resistance at the start of the trial were at greater risk of developing type 2 DM if assigned to the low-fat diet' . [2] He is correct that there was a significant interaction between intervention assignment and glycaemic control markers (insulin and homeostasis model assessment, insulin resistance). [6] In truth, however, there were no detectable differences between individual tertiles, [6] which limits the ability to make causative statements regarding subgroups. What is more, the absolute counts in the lowest tertiles were extremely small, mostly because data on glycaemic measures were available for only 2 816/45 887 participants. [6] Moreover, the true significance of any subgroup analysis should be viewed with scepticism. In effect, these analyses remove the protection from confounding that randomisation provides, and unless subgroup analyses are done only on a few, pre-specified endpoints, they can lead to erroneous conclusions. [7] Thus, Prof. Noakes' statement seems, at a minimum, overly confident regarding the effects of a low-fat dietary intervention for the primary prevention of DM.
Prof. Noakes' critique of the WHIRCDMT highlights several issues with the prescription of a low-fat diet, including the variability of effectiveness for different groups in the population. In particular, individuals with pre-existing CVD and DM may experience harmful effects when attempting to follow a low-fat diet. Nevertheless, the WHIRCDMT does not provide high-quality evidence that a lowfat diet emphasising fruits, vegetables and whole grains contributes disproportionately to the development of DM and weight gain.
While it can be agreed the WHIRCDMT was disappointing in many ways for researchers and clinicians alike, a more balanced approach to the interpretation of the results is warranted.
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